We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes

By LabMedica International staff writers
Posted on 06 Oct 2023

Diabetes is a metabolic disorder that commonly affects people who are over 45, have a family history of the disease, poor diet, or high BMI. More...

Poor management of diabetes can lead to severe complications like heart disease, kidney problems, and amputations. To keep the condition in check, it's crucial for patients to regularly test their glucose levels using methods like fasting blood glucose (FBG), oral glucose tolerance test (OGTT), and glycated hemoglobin (HbA1c) tests. Now, researchers have introduced a new way to monitor glucose levels through a non-invasive sensor that analyzes body fluids like saliva.

Scientists at the Baqiyatallah University of Medical Sciences (Tehran, Iran) have created a unique sensor that can identify diabetic patients by analyzing the metabolic changes in their saliva. This sensor uses an origami-like paper substrate made of two layers folded together. A saliva sample is placed on one layer and soaks through to the second layer where it interacts with sensor elements. Organic dyes serve as the sensor's receptors. Depending on their molecular structure, these dyes capture compounds in the saliva, resulting in visible color changes, according to the study published in Scientific Reports.

During clinical trials, this sensor demonstrated that it was capable of distinguishing between the chemical compositions of saliva from diabetic and non-diabetic individuals. It could also estimate the blood glucose levels or ranges and provide consistent results when analyzing specific samples. The color changes in the receptors were solely due to alterations in the saliva's metabolic profile. The sensor offers several benefits such as simplicity, portability, and reliable readings, making it a strong candidate to replace existing glucose monitoring methods. However, one current limitation is that the saliva samples need to be centrifuged, so the sensor is only suitable for use in clinical labs at this point.

Related Links:
Baqiyatallah University of Medical Sciences 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The SimpleScreen CRC platform uses multiomics, AI, and machine learning to analyze blood-based signals and detect cancer-associated patterns (Photo courtesy of Freenome)

Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions

Colorectal cancer is the second-leading cause of cancer-related death in the United States, yet screening uptake remains suboptimal. More than 50 million eligible adults are not up to date with recommended... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.